BSVN vs. BVS
BSVN (Bank7 Corp.) and BVS (Bioventus Inc.) are both stocks. BSVN operates in Banks - Regional (Financial Services), while BVS operates in Medical Devices (Healthcare). Over the past 5 years, BSVN returned 24.36%/yr vs -13.30%/yr for BVS. At a 0.17 correlation, their price movements are largely independent.
Performance
BSVN vs. BVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BSVN achieves a 12.85% return, which is significantly lower than BVS's 18.15% return.
BSVN
- 1D
- 0.00%
- 1M
- 4.87%
- YTD
- 12.85%
- 6M
- 8.53%
- 1Y
- 21.12%
- 3Y*
- 30.05%
- 5Y*
- 24.36%
- 10Y*
- —
BVS
- 1D
- 0.92%
- 1M
- -5.28%
- YTD
- 18.15%
- 6M
- 17.51%
- 1Y
- 34.20%
- 3Y*
- 43.25%
- 5Y*
- -13.30%
- 10Y*
- —
BSVN vs. BVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BSVN Bank7 Corp. | 12.85% | -10.03% | 75.30% | 10.03% | 13.72% | 41.76% |
BVS Bioventus Inc. | 18.15% | -29.14% | 99.24% | 101.92% | -81.99% | -4.04% |
Correlation
The correlation between BSVN and BVS is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Feb 11, 2021 | 0.17 |
Fundamentals
BSVN:
$438.10M
BVS:
$615.37M
BSVN:
$4.67
BVS:
$0.41
BSVN:
9.77
BVS:
21.32
BSVN:
0.53
BVS:
0.17
BSVN:
3.15
BVS:
1.05
BSVN:
1.69
BVS:
3.26
BSVN:
$138.85M
BVS:
$576.30M
BSVN:
$73.08M
BVS:
$390.14M
BSVN:
$43.92M
BVS:
$98.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BSVN vs. BVS — Risk / Return Rank
BSVN
BVS
BSVN vs. BVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bank7 Corp. (BSVN) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BSVN | BVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.13 | ||
| Sortino ratioReturn per unit of downside risk | -0.08 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.16 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.98 | 1.25 | -0.27 |
| Martin ratioReturn relative to average drawdown | 1.81 | 3.99 | -2.17 |
Loading charts...
Drawdowns
BSVN vs. BVS - Drawdown Comparison
The maximum BSVN drawdown since its inception was -70.03%, smaller than the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for BSVN and BVS.
Loading charts...
Drawdown Indicators
| BSVN | BVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.03% | -95.18% | +25.15% |
Max Drawdown (1Y)Largest decline over 1 year | -21.72% | -27.51% | +5.79% |
Max Drawdown (3Y)Largest decline over 3 years | -27.75% | -55.22% | +27.47% |
Max Drawdown (5Y)Largest decline over 5 years | -30.81% | -95.07% | +64.26% |
Current DrawdownCurrent decline from peak | -6.12% | -54.24% | +48.12% |
Average DrawdownAverage peak-to-trough decline | -14.87% | -56.33% | +41.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.67% | 8.60% | +3.07% |
Volatility
BSVN vs. BVS - Volatility Comparison
The current volatility for Bank7 Corp. (BSVN) is 5.59%, while Bioventus Inc. (BVS) has a volatility of 19.32%. This indicates that BSVN experiences smaller price fluctuations and is considered to be less risky than BVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BSVN | BVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.59% | 19.32% | -13.73% |
Volatility (6M)Calculated over the trailing 6-month period | 17.51% | 32.56% | -15.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.32% | 50.76% | -24.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.74% | 81.05% | -46.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.58% | 80.63% | -34.05% |
Dividends
BSVN vs. BVS - Dividend Comparison
BSVN's dividend yield for the trailing twelve months is around 2.37%, while BVS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
BSVN Bank7 Corp. | 2.37% | 2.49% | 1.93% | 2.71% | 2.03% | 1.96% | 3.59% | 3.16% |
BVS Bioventus Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BSVN vs. BVS - Financials Comparison
This section allows you to compare key financial metrics between Bank7 Corp. and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BSVN vs. BVS - Profitability Comparison
BSVN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bank7 Corp. reported a gross profit of 0.00 and revenue of 33.78M. Therefore, the gross margin over that period was 0.0%.
BVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a gross profit of 90.77M and revenue of 132.09M. Therefore, the gross margin over that period was 68.7%.
BSVN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bank7 Corp. reported an operating income of 0.00 and revenue of 33.78M, resulting in an operating margin of 0.0%.
BVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported an operating income of 8.42M and revenue of 132.09M, resulting in an operating margin of 6.4%.
BSVN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bank7 Corp. reported a net income of 12.01M and revenue of 33.78M, resulting in a net margin of 35.5%.
BVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a net income of 3.11M and revenue of 132.09M, resulting in a net margin of 2.4%.
Frequently Asked Questions
BSVN and BVS have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BVS has higher volatility (19.32%) compared to BSVN (5.59%). In terms of maximum drawdown, BSVN dropped -70.03% vs BVS's -95.18%.
BSVN currently has the higher Sharpe Ratio (0.81 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BSVN and BVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer